左心室卸载以促进心力衰竭中的心室重塑:关于机械循环支持的叙述性回顾
Fatima Kayali1, Owais Tahhan2, Guglielmo Vecchio1
1University Hospitals Sussex NHS Foundation Trust, Brighton and Hove, Sussex, UK.
Experimental physiology
|October 15, 2024
概括
机械循环支持装置有助于心力衰竭患者的心室卸载和重塑. 虽然改善了血液动力学,但结果是不同的,需要进一步的试验和个性化的设备选择.
科学领域:
- 心脏病学 心脏病学
- 生物医学工程 生物医学工程
背景情况:
- 心力衰竭在老龄化,多病症人口中是一个日益关注的问题.
- 机械循环支持 (MCS) 为心力衰竭管理提供了治疗选择.
研究的目的:
- 审查MCS设备在心脏衰竭中腹腔卸载和重塑中的作用.
- 突出关键MCS设备的特征,机制和临床结果.
主要方法:
- 关于心室辅助器件,ECMO,Impella和TandemHeart的叙述性审查.
- 分析生理变化 (中风体积,压力) 和临床结果.
主要成果:
- 所有审查的MCS策略都促进了心室卸载和重塑.
- 植入后立即发生生理变化,心脏功能有变化的改善.
- 在心脏性休克/高风险PCI患者中,Impella和TandemHeart改善了血液动力学,但没有改善存活率.
结论:
- MCS设备有效地卸载失败的心室,影响重塑.
- 设备的选择应根据患者的因素和指示进行个性化选择.
- 进一步进行高质量的试验至关重要,以充分评估临床结果.
相关概念视频
Cardiomyopathy V: Interprofessional Care
2
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
2
Heart Failure V: Medical Management
2
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
2
Cardiomyopathy II: Dilated Cardiomyopathy
1
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
1
Heart Failure VI: Adjunct Therapies
5
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
5
Heart Failure II: Pathophysiology
3
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
3
Cardiomyopathy III: Hypertrophic Cardiomyopathy
1
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
1


